APOE and metabolic dysfunction-associated steatotic liver disease: Thus, the deficiency of miR155 in ApoE-/- background leads to increased obesity, increased non-alcoholic fatty liver disease (NAFLD), decreased atherosclerosis, no insulin resistance and no type II diabetes mellitus (T2DM) (11).